In melanoma studies, it has been observed that activation of STING in tumor cells and DCs leads to increased infiltration of NK cells in the tumor microenvironment (TME) through the secretion of CXCL10 and CCL5 cytokines. This evidence concerns the gene STING1 and neoplasm.